ERBB2 and breast carcinoma: Moreover, changes in incidence trends for particular subtypes, such as ERBB2-positive breast cancers, that are consistent across all age groups or that are present for younger age groups who are not likely participating in breast cancer screening suggest a real change in risk for those subtypes rather than greater detection through increasing screening over time.